Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.
GLP-1 giant Eli Lilly has once again taken to the medium of short film to deliver an important message about obesity. | GLP-1 ...
Sun Pharma is evaluating a potential $10 billion acquisition of Organon, a move that could become India's largest ...
2don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
I think there’s common ground here,” one Republican congressman said Wednesday during a House Budget Committee hearing.
Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results